“Our network of regional partners is a vital component of the EXTEDO solution. Leading consultancy firms such as Inpharmatis provide our mutual clients with regional regulatory expertise and enable us to offer local product services and support,” said Christian Bohrmann, VP Marketing & Alliances at EXTEDO.

 

The EXTEDOsuite is the only Regulatory Information Management System to include planning & tracking, product registration, submission publishing, lifecycle management, pharmacovigilance management, and drug safety. Effortless Compliance™ ensures a healthy relationship between the industry and the authorities.

EXTEDO is proud to include the Baltic and CIS regions in our existing industry-leading partnerships portfolio.

About Inpharmatis

Inpharmatis is an international consulting company with headquarters in Riga, Latvia, with more than 15 years of proven experience in providing complete services in regulatory affairs, pharmacovigilance, GMP, and GDP as information technology solutions for the life science industry over the whole European & CIS market. Today, Inpharmatis is the only consulting company operating in the CIS region with complete geographical coverage of all 15 countries and only full-time multilingual employees.

About EXTEDO

EXTEDO is a leading solutions and services provider in the field of Regulatory Information Management (RIM). We focus on optimizing our clients’ eRegulatory business processes. We are the only vendor that provides solutions covering the entire regulatory landscape—our EXTEDOsuite combines innovation with compliance and quality with usability.

Whether planning & tracking, product registration, submission publishing, lifecycle management, pharmacovigilance management, and drug safety, we optimize every eRegulatory business process. Today, EXTEDO enables more than 35 regulatory authorities, and over 700 maintained customers across 60 countries to deliver Effortless Compliance™.

For more information, visit www.extedo.com.

 

All trade names, trademarks, and service marks are the rightful property of their respective owners.

whiteWaveTop

Latest Blog Posts

500

Interview: Meet EXTEDO’s eCTDtemplates!

500

Singapore's Transition to eCTD

500

Bertelsmann Investments Announces Another Major Investment in the Growing Pharma Tech Market

500

Interview: Meet EXTEDO’s Regulatory Intelligence (RI) Module!